SAVIENT PHARMACEUTICALS INC 4
4 · SAVIENT PHARMACEUTICALS INC · Filed Oct 17, 2013
Insider Transaction Report
Form 4
Hamill John
SVP, CFO
Transactions
- Sale
Common Stock
2013-10-15$0.08/sh−5,000$396→ 97,113 total - Sale
Common Stock
2013-10-15$0.08/sh−1,500$119→ 102,113 total - Sale
Common Stock
2013-10-15$0.08/sh−7,646$612→ 66,667 total - Sale
Common Stock
2013-10-15$0.08/sh−1,000$80→ 75,113 total - Sale
Common Stock
2013-10-15$0.08/sh−21,000$1,670→ 76,113 total - Sale
Common Stock
2013-10-15$0.08/sh−800$64→ 74,313 total